Shehnaaz Suliman
Director/Board Member at ULTRAGENYX PHARMACEUTICAL INC.
Net worth: 1 M $ as of 31/05/2024
Network origin in Shehnaaz Suliman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 38 | |
| Public Company | Biotechnology | 20 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Biotechnology | 11 | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.
10
| Holding Company | Pharmaceuticals: Major | 10 |
| Public Company | Pharmaceuticals: Major | 7 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada.
1
| Private Company | Pharmaceuticals: Major | 1 |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shehnaaz Suliman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| DIMENSION THERAPEUTICS INC | Biotechnology | President Director/Board Member Treasurer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Compliance Officer Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member Sales & Marketing Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Public Communications Contact Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Director/Board Member General Counsel | |
| United States Naval Academy | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Medical/Nursing Services | Director/Board Member Founder Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Graduate Degree Masters Business Admin Corporate Officer/Principal | |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member Chairman Chief Executive Officer | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
QuantaLife, Inc.
 QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member Founder Corporate Officer/Principal | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| Georgetown University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Doctorate Degree | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| NUVATION BIO INC. | Biotechnology | Chairman Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Graduate Degree Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Georgia Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| APEXIGEN, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member Chairman | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Chairman | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal Human Resources Officer | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact |
Statistics
International
| United States | 48 |
| Ireland | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 479 |
| Corporate Officer/Principal | 232 |
| Independent Dir/Board Member | 159 |
| Undergraduate Degree | 72 |
| Chairman | 71 |
Most connected contacts
| Insiders | |
|---|---|
| Bryan Roberts | 44 |
| Paul Conley | 39 |
| Peter Thompson | 39 |
| Helen Kim | 34 |
| Henrietta Holsman Fore | 33 |
| Alan Colowick | 30 |
| Edward Hurwitz | 27 |
| Claudia Dyckerhoff | 26 |
| Daniel Welch | 24 |
| Daniel Zabrowski | 23 |
| Christine Pellizzari | 22 |
| Lars Ekman | 21 |
| Deborah Dunsire | 20 |
| Kim Popovits | 19 |
| Beatrice Weder di Mauro | 19 |
- Stock Market
- Insiders
- Shehnaaz Suliman
- Company connections
